Kowa Research Institute, Inc.

🇺🇸United States
Ownership
Subsidiary
Established
1981-01-01
Employees
1
Market Cap
-
Website
http://www.kowaus.com
Clinical Trials
Related News

Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: K-877
Drug: Clopidogrel
First Posted Date
2016-10-04
Last Posted Date
2016-12-21
Lead Sponsor
Kowa Research Institute, Inc.
Target Recruit Count
20
Registration Number
NCT02922465

Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia

First Posted Date
2016-06-15
Last Posted Date
2021-05-10
Lead Sponsor
Kowa Research Institute, Inc.
Registration Number
NCT02799758

Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Warfarin
Drug: K-877
First Posted Date
2016-03-25
Last Posted Date
2016-03-25
Lead Sponsor
Kowa Research Institute, Inc.
Target Recruit Count
20
Registration Number
NCT02719431

Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312

Phase 1
Completed
Conditions
Dyslipidemia
Interventions
Drug: K-312 100 mg
Drug: K-312 100 ug C14 IV
First Posted Date
2016-02-08
Last Posted Date
2016-02-18
Lead Sponsor
Kowa Research Institute, Inc.
Target Recruit Count
13
Registration Number
NCT02676830

Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects

First Posted Date
2016-02-08
Last Posted Date
2016-02-12
Lead Sponsor
Kowa Research Institute, Inc.
Target Recruit Count
120
Registration Number
NCT02676596

Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia

First Posted Date
2016-02-01
Last Posted Date
2021-05-10
Lead Sponsor
Kowa Research Institute, Inc.
Registration Number
NCT02670434

A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Hyperlipidemia
First Posted Date
2015-12-17
Last Posted Date
2016-01-11
Lead Sponsor
Kowa Research Institute, Inc.
Target Recruit Count
18
Registration Number
NCT02634034

Drug-Drug Interaction Study in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: K-877
Drug: Rifampin
First Posted Date
2014-10-27
Last Posted Date
2016-02-01
Lead Sponsor
Kowa Research Institute, Inc.
Target Recruit Count
20
Registration Number
NCT02275962
Locations
🇺🇸

PPD, Austin, Texas, United States

Drug-Drug Interaction Study in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: K-877
Drug: Clarithromycin
First Posted Date
2014-10-27
Last Posted Date
2014-10-27
Lead Sponsor
Kowa Research Institute, Inc.
Target Recruit Count
20
Registration Number
NCT02275988
Locations
🇺🇸

PPD, Austin, Texas, United States

Drug-Drug Interaction Study in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: K-877
Drug: Cyclosporine
First Posted Date
2014-10-27
Last Posted Date
2014-10-27
Lead Sponsor
Kowa Research Institute, Inc.
Target Recruit Count
20
Registration Number
NCT02276001
Locations
🇺🇸

PPD, Austin, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy